Bi Asset Management Fondsmaeglerselskab A Biomarin Pharmaceutical Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

$8.88 Billion
Q1 2025

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 12,695 shares of BMRN stock, worth $754,844. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,695

Previous 28,061 54.76%

Holding current value

$754,844

Previous $1.84 Million 51.36%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$61.25 - $72.83 $941,167 - $1.12 Million	-15,366 Reduced 54.76%	12,695 $897,000
Q4 2024 Feb 13, 2025	BUY	$61.93 - $70.49 $105,528 - $120,114	1,704 Added 6.47%	28,061 $1.84 Million
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $1.67 Million - $2.27 Million	24,187 Added 1114.61%	26,357 $1.85 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $264,449 - $327,657	-3,553 Reduced 62.08%	2,170 $179,000
Q1 2024 May 03, 2024	SELL	$83.81 - $99.0 $236,344 - $279,180	-2,820 Reduced 33.01%	5,723 $500,000
Q4 2023 Feb 09, 2024	BUY	$76.22 - $98.51 $414,179 - $535,303	5,434 Added 174.78%	8,543 $824,000
Q2 2023 Aug 03, 2023	BUY	$86.68 - $100.3 $152,470 - $176,427	1,759 Added 130.3%	3,109 $269,000
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $398,251 - $532,288	-4,539 Reduced 77.08%	1,350 $131,000
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $3,884 - $5,214	48 Added 0.82%	5,889 $609,000
Q3 2022 Nov 07, 2022	BUY	$82.16 - $96.94 $78,134 - $92,189	951 Added 19.45%	5,841 $495,000
Q1 2022 May 11, 2022	BUY	$74.28 - $92.69 $363,229 - $453,254	4,890 New	4,890 $377,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $66,583 - $82,713	-917 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$71.87 - $131.03 $65,904 - $120,154	917 New	917 $70,000
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $110,694 - $150,214	-1,551 Closed	0 $0
Q4 2019 Mar 19, 2020	SELL	$64.27 - $86.37 $192,424 - $258,591	-2,994 Reduced 65.87%	1,551 $131,000
Q3 2019 Mar 19, 2020	BUY	$67.4 - $85.11 $70,230 - $88,684	1,042 Added 29.75%	4,545 $306,000
Q2 2019 Mar 19, 2020	BUY	$80.35 - $93.9 $281,466 - $328,931	3,503 New	3,503 $300,000

Others Institutions Holding BMRN

# of Institutions

666

Shares Held

186M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Biomarin Pharmaceutical Inc Transaction History